## 

## 

||abeg|
|---|---|
|LuYOd3ySaaLSnyl||
|SAILMIGISNOdS3Y.SAALSNYLAOLNAWALVLS||
|LYOd4yS.YOLIGNVLNSQNAdSOqNI||
|SAILIALLOVTWIONVNIA40LNAWALVLS||
|LAAHSADNV1VE||
|SLNNOOOV<br>SHLOLSALON||





## 

## 

## 








## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 



## 

||Unrestricted|Endowment|Total|Unrestricted|Endowment|Total|
|---|---|---|---|---|---|---|
||Fund|Fund|Fund|Fund|Fund|Fund|
||2023|2023|2023|2022|2022|2022|
||£|£|£|£|£|£|
|Incomefrom:|||||||
|Investments|97,035|-|97,035|98,907|-|98,907|
|Expenditureon:|||||||
|Charitableactivities|90,245|-|90,245|88,570|-|88,570|
|(Note3)|||||||
|Realisedlosson|||||||
|Investment||‘a|«||4,432|4,432|
|Net(losses)/gains|||||||
|oninvestments(Note|||||||
|4)|<br>-|<br>(236,871)|<br>(236,871)|<br>-|<br>177,630|<br>177,630|
|NetIncome/|||||||
|(Expenditure)|6,790|(236,871)|(230,081)|10,337|173,198|183,535|
|TotalFundsbrought|||||||
|forwardat1April|||||||
|2022|134,743|2,666,044|2,800,787|124,406|2,492,846|2,617,252|
|TotalFundscarried|||||||
|forwardat31March|||||||
|2023|141,533<br>|2,429,173<br>|2,570,706<br>|134,743<br>|2,666,044<br>|2,800,787<br>|



## 

## 



## 





## 

## 



## 

|ANALYSISOFEXPENDITURE|Direct|Support||Total|Total|
|---|---|---|---|---|---|
||costs|costs||2023|2022|
||£|£||£|£|
|GrantstoNorthLondonCollegiateSchool||||||
|MusicScholarshipawards|45,000||-|45,000|41,000|
|AdvancementofEducationinScience||||||
|-ScienceEquipment|10,510||-|10,510|-|
|-ScienceLaboratories<br>-RefurbishmentofGreenHouse|33,000<br>-||-<br>-|33,000<br>-|33,741<br>6,000|
|AnnualSciencePrize|150||-|150|150|
|Othercharitableandeducationalpurposes||||||
|-SupplementarygrantstoBursaryHolders|4,000||-|4,000|3,000|
|-Choralandinstrumentalmasterclasses|2,250||”|2,250|2,942|
|-Organrepair|-||-|-|9,000|
|UnusedamountsreturnedtoTrust|(8,265)|||(8,265)|(9,723)|
|Governance<br>Auditfee|-|3,600||3,600|2,460|
|Total|<br> <br>86,645|<br> <br> <br>3,600|<br> <br> <br>|<br> <br> <br>90,245|<br> <br> <br>88,570|
|INVESTMENTS||||||
|InvestmentsoftheTrustcomprise:||||Market|value|
|||||2023|2022|
|||||£|£|
|UKlistedequities||||251,504|362,384|
|M&GEquitiesFundforCharities<br>BlackRockCharitiesEquitiesFund<br>COIFCharitiesInvestmentFund<br>BlackRockGrowthandIncomeFund<br>COIFCharitiesFixedInterestFund<br>NewtonGrowthandIncomeFund||||<br>830,575<br>98,365<br>606,492<br>287,886<br>242,702<br>111,649|<br>884,638<br>99,424<br>630,111<br>317,547<br>258,272<br>113,668|
|||||<br>2,429,173|<br>2,666,044|
|Movementsduringtheyearwere:||||<br>Market|<br>Market|
|||||Value2023|Value2022|
|||||£|£|
|Broughtforwardat1April2022<br>Realisedloss oninvestment<br>Unrealised(losses)/gains||||2,666,044<br>-<br>(236,871)|2,492,846<br>(4,432)<br>177,630|
|Carriedforwardat31March2023||||2,429,173<br>|2,666,044<br>|
|Investmentmanagerfeesarerecoveredwithin|pooledinvestment|funds||||





## 

|ACCRUEDINCOME||||2023|2022|
|---|---|---|---|---|---|
|||||£|£|
|GlaxoSmithKlineincome||||2,420|5,060|
|NewtonGrowthandIncomeFund||||400|360|
|BlackRock-InvestmentFunds||||3,050|2,875|
|||||5,870|8,295|
|CREDITORS||||2023|2022|
|||||£|£|
|NorthLondonCollegiateSchool||||166,887|80,241|
|Othercreditors||||3,600|2,460|
|||||170,487|82,701|
|TRUSTEES||||||
|NoneoftheTrusteesreceivedanyremuneration.||||||
|NETMOVEMENTINFUNDS||||||
|Netmovementinfundsfortheyearisstatedaftercharging|||thefollowing:|2023|2022|
|||||£|£|
|Amountspaidtoauditors||||||
|Auditservices—CroweU.K.LLP||||3,600|2,460|
|||||3,600|2,460|
|ANALYSISOFNETASSETSBETWEENFUNDS||||||
|Fundbalancesat31March2023are|representedby:|||||
|||||Total|Total|
||Unrestricted||Endowment|Funds|Funds|
||Funds||Funds|2023|2022|
|||£|£|£|£|
|FixedAssetsandInvestments||-|2,429,173|2,429,173|2,666,044|
|CurrentAssets|312,020||-|312,020|217,444|
|Creditors||||||
|Amountsfallingduewithinoneyear|(170,487)||-|(170,487)|(82,701)|
|Carriedforwardat31March2023|<br>141,533||<br>2,429,173|<br>2,570,706|<br>2,800,787|





## 

## 

|||At1April|||Unrealised|At31March|
|---|---|---|---|---|---|---|
|||2022|Income|Expenditure|loss|2023|
|||£|£|£|£|£|
||EndowmentFunds|2,666,044|-|-|(236,871)|2,429,173|
||UnrestrictedFunds|134,743|97,035|(90,245)|-|141,533|
||Total|<br>2,800,787<br>|<br> <br>97,035<br> <br>|<br> <br> <br>(90,245)<br> <br> <br>|<br> <br> <br>(236,871)<br> <br> <br>|<br> <br> <br>2,570,706<br> <br> <br>|
|11|COMPARATIVENOTES-ANALYSISOFNETASSETS|||BETWEENFUNDS|||
||Fundbalancesat31March2022arerepresentedby:||||Total|Total|
||||Unrestricted|Endowment|Funds|Funds|
||||Funds|Funds|2022|2021|
||||£|£|£|£|
||FixedAssetsandInvestments||-|2,666,044|2,666,044|2,492,846|
||CurrentAssets||217,444|-|217,444|239,156|
||Creditors<br>Amountsfallingduewithinoneyear||<br>(82,701)|<br> <br>-|<br> <br>(82,701)|<br>(114,750)|
||Carriedforwardat31March2022||<br> <br>134,743|<br> <br>2,666044|<br> <br>2,800,787|<br> <br>2,617,252|
||COMPARATIVENOTES-STATEMENT||OFFUNDS||||
|||At1April|||(Realisedloss)|At31March|
|||2021|Income.|Expenditure|unrealisedgain|2022|
|||£|<br>£|<br>£|<br>£|£|
||EndowmentFunds|2,492,846|-|-|(4,432)||
||||||177,630|2,666,044|
||UnrestrictedFunds|124,406|98,907|<br>(88,570)||<br>134,743|
||Total|<br>2,617,252<br>|<br> <br>98,907<br> <br>|<br> <br> <br>(88,570)<br> <br> <br>|<br> <br> <br>173,198<br> <br> <br>|<br> <br> <br>2,800,787<br> <br> <br>|





# 

## 

##